TNF and COVID-19: TNF-α inhibitors, such as adalimumab, certolizumab, etanercept, golimumab, and infliximab may serve as prospective therapeutics in COVID-19 treatment [Drugs.com, 2020a (Adalimumab); Drugs.com, 2020f (Certolizumab); Drugs.com, 2020h (Etanercept); Drugs.com, 2020i (Golimumab); Drugs.com, 2020k (Infliximab)].